Targeting Inflammation as a Therapeutic Strategy in Accelerated Atherosclerosis in Rheumatoid Arthritis
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Inflammation as a Therapeutic Strategy in Accelerated Atherosclerosis in Rheumatoid Arthritis
Authors
Keywords
-
Journal
Cardiovascular Therapeutics
Volume 29, Issue 4, Pages 231-242
Publisher
Wiley
Online
2010-06-15
DOI
10.1111/j.1755-5922.2010.00159.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation
- (2010) L. L. Santos et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
- (2009) T. E. Toms et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
- (2009) M J L Peters et al. ANNALS OF THE RHEUMATIC DISEASES
- Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
- (2009) E Choy et al. ANNALS OF THE RHEUMATIC DISEASES
- No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: Results from two Swedish population-based rheumatoid arthritis cohorts
- (2009) Marie E. Holmqvist et al. ARTHRITIS AND RHEUMATISM
- Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
- (2009) Mike J. L. Peters et al. ARTHRITIS AND RHEUMATISM
- Innate Immunity and Toll-like Receptor Antagonists: A Potential Role in the Treatment of Cardiovascular Diseases
- (2009) Elaine Lin et al. Cardiovascular Therapeutics
- Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice
- (2009) Myles J. Lewis et al. CIRCULATION
- Toll-Like Receptor-2 Mediates Inflammation and Matrix Degradation in Human Atherosclerosis
- (2009) Claudia Monaco et al. CIRCULATION
- Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis
- (2009) György Kerekes et al. CLINICAL RHEUMATOLOGY
- The role of Toll-like receptors in chronic inflammation
- (2009) Stefan K. Drexler et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Prevalence and Factors Associated With Metabolic Syndrome in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus
- (2009) Abraham Zonana-Nacach et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
- (2009) PAUL M. RIDKER JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease
- (2009) Kim Midwood et al. NATURE MEDICINE
- Role for TNF in atherosclerosis? Lessons from autoimmune disease
- (2009) Gayle E. McKellar et al. Nature Reviews Cardiology
- Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
- (2009) L. A. J. O'Neill et al. PHARMACOLOGICAL REVIEWS
- Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
- (2009) Jean-Michel Dayer et al. RHEUMATOLOGY
- The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus
- (2009) Louise E Full et al. ARTHRITIS RESEARCH & THERAPY
- Role of Inflammation in Atherosclerosis Associated with Rheumatoid Arthritis
- (2008) Peter Libby AMERICAN JOURNAL OF MEDICINE
- Anti-tumour necrosis factor agents and lipid profile: a class effect?
- (2008) S P Garces et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor α blocker therapy
- (2008) Carlos Gonzalez-Juanatey et al. ARTHRITIS AND RHEUMATISM
- Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
- (2008) Joachim Listing et al. ARTHRITIS AND RHEUMATISM
- High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study
- (2008) Hilal Maradit Kremers et al. ARTHRITIS AND RHEUMATISM
- Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid Arthritis
- (2008) Andreas J. Flammer et al. CIRCULATION
- Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction
- (2008) Yuh Ishikawa et al. CLINICAL SCIENCE
- Toll-like receptor modulation: A novel therapeutic strategy in cardiovascular disease?
- (2008) Athanasios Katsargyris et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events
- (2008) Adam E. Mullick et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Oxidation-specific epitopes are important targets of innate immunity
- (2008) M.-Y. Chou et al. JOURNAL OF INTERNAL MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study)
- (2008) David C Crossman et al. Trials
- Mechanisms of Disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis
- (2008) Sally Ayoub et al. Nature clinical practice. Rheumatology
- Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids
- (2007) Xinyan Liu et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started